Items where authors include "Orbai, A-M"

Article

Orbai, A-M, Coates, LC, Deodhar, A et al. (10 more authors) (2022) Meaningful Improvement in General Health Outcomes with Guselkumab Treatment for Psoriatic Arthritis: Patient-Reported Outcomes Measurement Information System-29 Results from a Phase 3 Study. The Patient: Patient Centered Outcomes Research, 15 (6). pp. 657-668. ISSN 1178-1653

Orbai, A-M, Mease, PJ, Helliwell, PS orcid.org/0000-0002-4155-9105 et al. (4 more authors) (2022) Effect of tofacitinib on dactylitis and patient-reported outcomes in patients with active psoriatic arthritis: post-hoc analysis of phase III studies. BMC Rheumatology, 6 (1). 68. ISSN 2520-1026

Gladman, DD, Orbai, A-M, Klitz, U et al. (6 more authors) (2019) Ixekizumab and complete resolution of enthesitis and dactylitis: integrated analysis of two phase 3 randomized trials in psoriatic arthritis. Arthritis Research and Therapy, 21. ARTN 38. ISSN 1478-6354

Coates, LC orcid.org/0000-0002-4756-663X, Orbai, A-M, Morita, A et al. (6 more authors) (2018) Achieving minimal disease activity in psoriatic arthritis predicts meaningful improvements in patients’ health-related quality of life and productivity. BMC Rheumatology, 2 (1). 24. ISSN 2520-1026

Højgaard, P, Klokker, L, Orbai, A-M et al. (17 more authors) (2018) A systematic review of measurement properties of patient reported outcome measures in psoriatic arthritis: A GRAPPA-OMERACT initiative. Seminars in Arthritis and Rheumatism, 47 (5). pp. 654-665. ISSN 0049-0172

Halls, S, Sinnathurai, P, Hewlett, S et al. (15 more authors) (2017) Stiffness Is the Cardinal Symptom of Inflammatory Musculoskeletal Diseases, Yet Still Variably Measured: Report from the OMERACT 2016 Stiffness Special Interest Group. Journal of Rheumatology, 44 (12). pp. 1904-1910. ISSN 0315-162X

Tillett, W, Dures, E, Hewlett, S et al. (9 more authors) (2017) A Multicenter Nominal Group Study to Rank Outcomes Important to Patients, and Their Representation in Existing Composite Outcome Measures for Psoriatic Arthritis. The Journal of Rheumatology, 44 (10). pp. 1445-1452. ISSN 0315-162X

Orbai, A-M, Mease, PJ, de Wit, M et al. (15 more authors) (2016) Report of the GRAPPA-OMERACT Psoriatic Arthritis Working Group from the GRAPPA 2015 Annual Meeting. The Journal of Rheumatology, 43 (5). pp. 965-969. ISSN 0315-162X

Conference or Workshop Item

Mease, P, Orbai, A-M, FitzGerald, O et al. (5 more authors) (2021) Efficacy of Tofacitinib on Enthesitis in Patients with Active Psoriatic Arthritis. In: ACR Convergence 2021, 05-09 Nov 2021, Online.

Orbai, A-M, Coates, L, Deodhar, A et al. (9 more authors) (2021) Guselkumab-Treated Patients with Psoriatic Arthritis Achieved Clinically Meaningful Improvements in General Health Outcomes Measured with PROMIS-29 Through 52 Weeks: Results from the Phase 3 DISCOVER-1 Trial. In: ACR Convergence 2021, 05-09 Nov 2021, Online.

Orbai, A-M, Mease, P, Helliwell, P orcid.org/0000-0002-4155-9105 et al. (5 more authors) (2020) Efficacy of Tofacitinib on Dactylitis in Individual Digits in Patients with Active Psoriatic Arthritis. In: ACR Convergence 2020, 05-09 Nov 2020, Virtual.

Orbai, A-M, Coates, L, Deodhar, A et al. (8 more authors) (2020) Guselkumab-Treated Patients Achieved Clinically Meaningful Improvement in Systemic Symptoms as Measured with PROMIS Instrument: Results from Phase-3 Psoriatic Arthritis Trial DISCOVER 1. In: ACR Convergence 2020, 05-09 Nov 2020, Virtual.

Proceedings Paper

Duarte-Garcia, A, Eder, L, Stephens-Shields, A et al. (13 more authors) (2018) Construct Validity of the Swollen and Tender Joint Counts for the Measurement of MSK Disease Activity in Psoriatic Arthritis. In: Arthritis and Rheumatology. 2018 ACR/ARHP Annual Meeting, 19-24 Oct 2018, Chicago, IL, USA. Wiley .